Trial intelligence / Profile preview

Nebulized salbutamol + magnesium sulfate versus nebulized salbutamol alone in acute asthma attack

IRCT2015111015446N8Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of salbutamol and magnesium sulfate in asthma (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Clinical response and Spirometric response. Started Mar 2014; status: completed.

02

Drugs

salbutamolmagnesium sulfate
03

Conditions

asthma

Beyond the preview

Go deeper on IRCT2015111015446N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015111015446N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call